Chronic Myelogenous Leukemia
2 competing products in clinical development for Chronic Myelogenous Leukemia.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| decitabine (5-aza-2'deoxycytidine) | Eisai | Phase 2 | Completed | 35 |
| decitabine (5-aza-2'deoxycytidine) | Eisai | Phase 2 | Completed | 35 |